News & Updates
Showing Neurology articles
Showing
Show Multimedia Only
Safinamide for Parkinson’s: Dyskinesia up short term, motor symptoms down long term
12 Oct 2022
byNatalia Reoutova
A post-hoc analysis of a phase III trial of long-term safinamide for Parkinson’s disease (PD) finds a significant early increase in pre-existing dyskinesia as well as improved motor symptoms in patients with or without pre-existing dyskinesia at 1 year.
Safinamide for Parkinson’s: Dyskinesia up short term, motor symptoms down long term
12 Oct 2022
Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis
10 Oct 2022
The use of dimethyl fumarate (DMF) in the treatment of children with paediatric-onset multiple sclerosis (POMS) appears to produce more favourable effects than interferon β-1a (IFNβ-1a), with those on DMF being less likely to have new or newly enlarging lesions and experience relapse, according to data from the open-label CONNECT study.
Dimethyl fumarate bests interferon β-1a in paediatric-onset multiple sclerosis
10 Oct 2022
Early sleep, longer time in bed tied to dementia risk in older adults
07 Oct 2022
Older adults who sleep before 9 P.M. and have prolonged sleep duration appear to be at an increased risk of dementia, a recent study has found.
